Plain-English translation of NCT07147517 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
The PREVENT study is tracking how respiratory viruses—including COVID-19, flu, and RSV—spread through communities and households. Researchers will ask participants to report symptoms, provide nasal swabs and blood samples, and answer health questions over time. This information will help scientists understand virus transmission and prepare better public health responses.
Right now, we don't fully understand how respiratory viruses move from person to person in real-world settings. By carefully studying virus spread in homes and communities, researchers can develop better strategies to prevent future outbreaks and protect public health.
You likely qualify if…
You likely don't qualify if…
Depending on which component you join, you might simply provide your information for screening, or you could participate in ongoing tracking for up to 2 years. Participants report symptoms weekly, provide nasal swabs when sick (and sometimes when well), complete questionnaires on days 0, 7, and 14 of illness, and may donate blood or saliva samples twice yearly. Those in the household transmission component do daily symptom check-ins and nasal swabs for 14 days after someone in the home tests positive.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States